Accepted for Publication: September 22, 2022.
Published: November 7, 2022. doi:10.1001/jamanetworkopen.2022.40526
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Black JC et al. JAMA Network Open.
Corresponding Author: Joshua C. Black, PhD, Rocky Mountain Poison & Drug Safety, Denver Health and Hospital Authority, 777 Bannock St, MC 0180, Denver, CO 80204 (joshua.black@rmpds.org).
Author Contributions: Dr Black had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Black, Amioka, Iwanicki, Monte.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Black, Amioka, Iwanicki, Monte.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Black, Amioka.
Administrative, technical, or material support: Black, Iwanicki, Dart.
Supervision: Iwanicki, Dart, Monte.
Conflict of Interest Disclosures: Dr Monte reported serving on the scientific advisory board for Anebulo Pharmaceuticals and receiving personal fees from Anebulo Pharmaceuticals. No other disclosures were reported.
Additional Information: The RADARS System is the property of the Denver Health and Hospital Authority (DHHA), a political subdivision of the State of Colorado. The DHHA retains exclusive ownership of all data, databases and systems.
2.Czeisler
MÉ , Lane
RI , Petrosky
E ,
et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(32):1049-1057. doi:
10.15585/mmwr.mm6932a1PubMedGoogle ScholarCrossref 3.Black
JC , Rockhill
K , Forber
A ,
et al. An online survey for pharmacoepidemiological investigation (survey of non-medical use of prescription drugs program): validation study.
J Med Internet Res. 2019;21(10):e15830. doi:
10.2196/15830PubMedGoogle ScholarCrossref